Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-001 Universal Influenza Vaccine in Older Adults
NCT03450915Phase 3Completed
- Sponsor
- Scinai Immunotherapeutics Ltd.
- Start
- Aug 2018
- Primary completion
- Jul 2020
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of multimeric-001 in influenza, sponsored by Scinai Immunotherapeutics Ltd.. Started Aug 2018; status: completed.
02
Drugs
multimeric-001
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03450915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03450915.